RARTEGLA Trademark

Trademark Overview


On Friday, September 30, 2022, a trademark application was filed for RARTEGLA with the United States Patent and Trademark Office. The USPTO has given the RARTEGLA trademark a serial number of 79356456. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by Novartis AG. The RARTEGLA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
rartegla

General Information


Serial Number79356456
Word MarkRARTEGLA
Filing DateFriday, September 30, 2022
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064553
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, August 6, 2023NOTIFICATION PROCESSED BY IB
Thursday, July 20, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 20, 2023FINAL DISPOSITION PROCESSED
Thursday, June 29, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023ASSIGNED TO EXAMINER
Tuesday, December 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 10, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, December 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 5, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 1, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB